NEW YORK (GenomeWeb News) — In a move that may transform the flow cytometry industry, start-up biotech Accuri Cytometers last week launched a flow cytometer that it believes is as good as or better than market-leading instruments with similar specifications, but costs about 75 percent less.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.